BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2551531)

  • 1. Thyrotropin-releasing hormone given intrathecally to the rat increases arterial pressure and heart rate.
    Yashpal K; Gauthier S; Henry JL
    Circ Res; 1989 Oct; 65(4):859-68. PubMed ID: 2551531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin administered intrathecally preferentially increases heart rate rather than arterial pressure in the rat.
    Yashpal K; Gauthier S; Henry JL
    J Auton Nerv Syst; 1987 Aug; 20(2):167-78. PubMed ID: 3668162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular responses to intrathecal administration of L- and D-baclofen in the rat.
    Hong Y; Henry JL
    Eur J Pharmacol; 1991 Jan; 192(1):55-62. PubMed ID: 1645677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat.
    Hong YG; Henry JL
    Brain Res; 1992 Jan; 569(1):38-45. PubMed ID: 1351773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal mediation of the increases in arterial pressure and heart rate in response to intrathecal administration of bicuculline.
    Hong Y; Henry JL
    Brain Res; 1990 Apr; 513(1):86-93. PubMed ID: 1972033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
    Okuda C; Mizobe T; Miyazaki M
    Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P given intrathecally at the spinal T9 level increases arterial pressure and heart rate in the rat.
    Yashpal K; Gauthier S; Henry JL
    J Auton Nerv Syst; 1987 Feb; 18(2):93-103. PubMed ID: 2437174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of non-NMDA receptor agonists increases arterial pressure and heart rate in the rat.
    Hong Y; Henry JL
    Brain Res; 1992 Sep; 591(1):62-8. PubMed ID: 1359919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intracerebroventricular administration of thyrotrophic-releasing hormone on cardiovascular function in the rat.
    Tsay BL; Lin MT
    Neuroendocrinology; 1982; 35(3):173-7. PubMed ID: 6813757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peripheral and central catecholaminergic and cholinergic mechanisms in the cardiovascular effects of thyrotropin-releasing hormone.
    Nurminen ML; Paakkari I
    Neuropeptides; 1991 Dec; 20(4):247-53. PubMed ID: 1667428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathomimetic pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H86-92. PubMed ID: 3089031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II stimulates sympathetic output by a direct spinal action.
    Yashpal K; Gauthier S; Henry JL
    Neuropeptides; 1989 Jul; 14(1):21-9. PubMed ID: 2779757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
    Evequoz D; Burnier M; Niederberger M; Brunner HR; Nussberger J; Waeber B
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):93-100. PubMed ID: 8039276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects produced by injections of thyrotropin-releasing hormone in specific preoptic and hypothalamic nuclei in the rat.
    Diz DI; Jacobowitz DM
    Peptides; 1984; 5(4):801-8. PubMed ID: 6436799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioacceleration provoked by intrathecal administration of vasoactive intestinal peptide (VIP): mediation by a non-central nervous system mechanism.
    Rochford J; Henry JL
    Neuropeptides; 1989; 14(4):243-52. PubMed ID: 2482950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of intrathecally administered 5-hydroxytryptamine and thyrotropin-releasing hormone on renal and muscle sympathetic nerve activity.
    Yusof AP; Coote JH
    J Auton Nerv Syst; 1988 Sep; 23(3):181-7. PubMed ID: 3142946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.